Yamanokuchi Satoshi, Ikai Iwao, Nishitai Ryuta, Matsushita Takakazu, Sugimoto Shinichi, Shiotani Tomohiro, Yamaoka Yoshio
Department of Gastroenterological Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
J Surg Res. 2005 Nov;129(1):57-63. doi: 10.1016/j.jss.2005.07.009. Epub 2005 Sep 2.
Secondary lymphoid organs are considered to be the only organs in which APCs and naïve T cells interact to initiate adaptive immune responses. Aly/aly mice are autosomal recessive mutants of C57BL/6 mice, and lack lymph nodes and Peyer's patches. In this study, we investigated immune responses to skin allografts in splenectomized aly/aly mice, which lack secondary lymphoid organs completely, and examined the effect of anti-asialo GM1 (AsGM1) antibodies on these responses.
Skin allografts were transplanted to 1) heterozygous aly/+ mice, which had normal secondary lymphoid organs, 2) splenectomized aly/+ mice, 3) aly/aly mice, and 4) splenectomized aly/aly mice, with and without anti-AsGM1 antibody treatment. Graft survival time and alloreactive antibody production were investigated.
Heterozygous aly/+ mice and splenectomized aly/+ mice rejected skin allografts acutely. Aly/aly mice also rejected skin allografts, but at a later time than aly/+ mice. Sixty percent of splenectomized aly/aly mice rejected skin allografts within 120 days. Serial administration of anti-AsGM1 antibodies prevented skin allograft rejection in splenectomized aly/aly mice during the same 120-day period of observation. After ceasation of anti-AsGM1 antibody treatment, skin allografts were rejected; we observed a simultaneous increase in AsGM1 expression on CD8+ T cells. Alloreactive antibodies were detected in both splenectomized aly/aly mice that rejected skin allografts and in splenectomized aly/aly mice that accepted skin allografts after treatment with anti-AsGM1 antibodies.
Cytotoxic and humoral immune responses to skin allografts could be initiated despite the absence of secondary lymphoid organs. AsGM1+ cells were important effector cells in secondary lymphoid organ-independent skin allograft rejection.
次级淋巴器官被认为是仅有的抗原呈递细胞(APC)与初始T细胞相互作用以启动适应性免疫反应的器官。Aly/aly小鼠是C57BL/6小鼠的常染色体隐性突变体,缺乏淋巴结和派伊尔结。在本研究中,我们调查了完全缺乏次级淋巴器官的脾切除Aly/aly小鼠对皮肤同种异体移植的免疫反应,并检测了抗去唾液酸GM1(AsGM1)抗体对这些反应的影响。
将皮肤同种异体移植物移植到1)具有正常次级淋巴器官的杂合Aly/+小鼠、2)脾切除的Aly/+小鼠、3)Aly/aly小鼠以及4)接受和未接受抗AsGM1抗体治疗的脾切除Aly/aly小鼠。研究移植物存活时间和同种异体反应性抗体产生情况。
杂合Aly/+小鼠和脾切除的Aly/+小鼠急性排斥皮肤同种异体移植物。Aly/aly小鼠也排斥皮肤同种异体移植物,但时间比Aly/+小鼠晚。60%的脾切除Aly/aly小鼠在120天内排斥皮肤同种异体移植物。在相同的120天观察期内,连续给予抗AsGM1抗体可防止脾切除的Aly/aly小鼠排斥皮肤同种异体移植物。停止抗AsGM1抗体治疗后,皮肤同种异体移植物被排斥;我们观察到CD8+T细胞上AsGM1表达同时增加。在排斥皮肤同种异体移植物的脾切除Aly/aly小鼠以及接受抗AsGM1抗体治疗后接受皮肤同种异体移植物的脾切除Aly/aly小鼠中均检测到同种异体反应性抗体。
尽管没有次级淋巴器官,对皮肤同种异体移植物的细胞毒性和体液免疫反应仍可启动。AsGM1+细胞是不依赖次级淋巴器官的皮肤同种异体移植排斥反应中的重要效应细胞。